Hildegunn Aarsetoey

Summary

Affiliation: Stavanger University Hospital
Country: Norway

Publications

  1. ncbi request reprint Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction
    H Aarsetøy
    Department of Medicine, Stavanger University Hospital, Stavanger, Norway
    Eur J Clin Nutr 62:411-8. 2008
  2. doi request reprint Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction
    Hildegunn Aarsetøy
    Department of Medicine, Stavanger University Hospital, Stavanger, Norway
    Resuscitation 78:258-64. 2008
  3. pmc Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, PB 8100, 4068 Stavanger, Norway
    Lipids 46:151-61. 2011
  4. doi request reprint (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, 4068 Stavanger, Norway
    J Nutr 139:507-13. 2009
  5. pmc Prognostic utility of vitamin d in acute coronary syndrome patients in coastal norway
    Patrycja A Naesgaard
    Department of Cardiology, Stavanger University Hospital, Stavanger, Norway Department of Clinical Science, University of Bergen, Bergen, Norway
    Dis Markers 2015:283178. 2015
  6. pmc The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, 4011 Stavanger, Norway
    Cardiol Res Pract 2012:303456. 2012

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction
    H Aarsetøy
    Department of Medicine, Stavanger University Hospital, Stavanger, Norway
    Eur J Clin Nutr 62:411-8. 2008
    ....
  2. doi request reprint Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction
    Hildegunn Aarsetøy
    Department of Medicine, Stavanger University Hospital, Stavanger, Norway
    Resuscitation 78:258-64. 2008
    ..Whether high levels of n-3 FAs could protect against ventricular fibrillation (VF) during the acute ischaemic phase of a myocardial infarction (MI) is, however, not known...
  3. pmc Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, PB 8100, 4068 Stavanger, Norway
    Lipids 46:151-61. 2011
    ..25-0.76%) reduction in risk of ventricular fibrillation (VF). In conclusion, the omega-3 index remained stable after an event of SCA and predicted the risk of VF...
  4. doi request reprint (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, 4068 Stavanger, Norway
    J Nutr 139:507-13. 2009
    ..In conclusion, we could not confirm the omega-3 index as a useful prognostic risk marker following an ACS...
  5. pmc Prognostic utility of vitamin d in acute coronary syndrome patients in coastal norway
    Patrycja A Naesgaard
    Department of Cardiology, Stavanger University Hospital, Stavanger, Norway Department of Clinical Science, University of Bergen, Bergen, Norway
    Dis Markers 2015:283178. 2015
    ..358, P < 0.001. Conclusion. Vitamin D levels are related to survival, especially in females, and correlate with the omega-3 index. ..
  6. pmc The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease
    Hildegunn Aarsetoey
    Department of Medicine, Stavanger University Hospital, 4011 Stavanger, Norway
    Cardiol Res Pract 2012:303456. 2012
    ..evaluating the efficacy of n-3 PUFAs on CVD, including 12 common studies, but drawing opposite conclusions. We definitely need more large-scale, randomized clinical trials of long duration, also reporting harmful effects of n-3 PUFAs...